×
About 696 results

ALLMedicine Cardiac Markers Center

Research & Reviews  323 results

Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocard...
https://doi.org/10.1007/s10557-020-07006-9
Cardiovascular Drugs and Therapy; Eid RA, Khalil MA et. al.

May 31st, 2020 - This study tested if the protective anti-remodeling effect of GLP-1 agonist Exendin-4 after an acute myocardial infarction (MI) in rats involves inhibition of the Wnt1/β-catenin signaling pathway. Rats were divided into sham, sham + Exendin-4 (10 ...

ACUTE INFLAMMATION AND ELEVATED CARDIAC MARKERS IN A TWO-MONTH-OLD INFANT WITH SEVERE A...
https://doi.org/10.1097/INF.0000000000002750
The Pediatric Infectious Disease Journal; Giacomet V, Manfredini VA et. al.

May 20th, 2020 - Severe acute respiratory syndrome coronavirus 2 infection in children mainly shows a milder course. In complicated cases, it is unknown whether inflammation is predictive of disease severity, as in adults. Moreover, cardiac involvement is anecdota...

The clinically effective use of cardiac markers by restructuring laboratory profiles at...
https://doi.org/10.1515/cclm-2019-1229
Clinical Chemistry and Laboratory Medicine; Keppel MH, Kolbitsch T et. al.

Apr 19th, 2020 - Background Laboratory overutilization is associated with diagnostic error and potential patient risk. We applied a demand management strategy in collaboration with the local Department of Cardiology to reduce the cardiac markers high-sensitive tro...

No-reflow phenomenon during percutaneous coronary intervention in a patient with polycy...
https://doi.org/10.1097/MD.0000000000019288
Medicine Oktaviono YH, Hutomo SA et. al.

Mar 2nd, 2020 - Acute myocardial infarction is the leading cause of mortality and morbidity in a patient with polycythemia vera (PV). However, the benefit of various percutaneous coronary intervention (PCI) technique on the patient with PV is relatively unexplore...

In Vitro Demonstration of Drug-Reagent Interactions Among Commonly Used Parenteral Drug...
https://doi.org/10.2174/1871525718666200226115235
Cardiovascular & Hematological Agents in Medicinal Chemistry; Gönel A, Tascanov MB et. al.

Feb 24th, 2020 - Drug-drug interactions are undesirable, as they reduce drug bioavailability. Drug-reagent interactions in biochemical tests may directly affect the accuracy of test results. The aim of the present study was to investigate the impact of drug-reagen...

see more →

Guidelines  1 results

Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute C...
https://doi.org/10.1373/clinchem.2017.277186
Clinical Chemistry; Wu AHB, Christenson RH et. al.

Jan 18th, 2018 - This document is an essential companion to the third iteration of the National Academy of Clinical Biochemistry [NACB,8 now the American Association for Clinical Chemistry (AACC) Academy] Laboratory Medicine Practice Guidelines (LMPG) on cardiac m...

see more →

Clinicaltrials.gov  349 results

Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocard...
https://doi.org/10.1007/s10557-020-07006-9
Cardiovascular Drugs and Therapy; Eid RA, Khalil MA et. al.

May 31st, 2020 - This study tested if the protective anti-remodeling effect of GLP-1 agonist Exendin-4 after an acute myocardial infarction (MI) in rats involves inhibition of the Wnt1/β-catenin signaling pathway. Rats were divided into sham, sham + Exendin-4 (10 ...

ACUTE INFLAMMATION AND ELEVATED CARDIAC MARKERS IN A TWO-MONTH-OLD INFANT WITH SEVERE A...
https://doi.org/10.1097/INF.0000000000002750
The Pediatric Infectious Disease Journal; Giacomet V, Manfredini VA et. al.

May 20th, 2020 - Severe acute respiratory syndrome coronavirus 2 infection in children mainly shows a milder course. In complicated cases, it is unknown whether inflammation is predictive of disease severity, as in adults. Moreover, cardiac involvement is anecdota...

The clinically effective use of cardiac markers by restructuring laboratory profiles at...
https://doi.org/10.1515/cclm-2019-1229
Clinical Chemistry and Laboratory Medicine; Keppel MH, Kolbitsch T et. al.

Apr 19th, 2020 - Background Laboratory overutilization is associated with diagnostic error and potential patient risk. We applied a demand management strategy in collaboration with the local Department of Cardiology to reduce the cardiac markers high-sensitive tro...

No-reflow phenomenon during percutaneous coronary intervention in a patient with polycy...
https://doi.org/10.1097/MD.0000000000019288
Medicine Oktaviono YH, Hutomo SA et. al.

Mar 2nd, 2020 - Acute myocardial infarction is the leading cause of mortality and morbidity in a patient with polycythemia vera (PV). However, the benefit of various percutaneous coronary intervention (PCI) technique on the patient with PV is relatively unexplore...

In Vitro Demonstration of Drug-Reagent Interactions Among Commonly Used Parenteral Drug...
https://doi.org/10.2174/1871525718666200226115235
Cardiovascular & Hematological Agents in Medicinal Chemistry; Gönel A, Tascanov MB et. al.

Feb 24th, 2020 - Drug-drug interactions are undesirable, as they reduce drug bioavailability. Drug-reagent interactions in biochemical tests may directly affect the accuracy of test results. The aim of the present study was to investigate the impact of drug-reagen...

see more →

News  23 results

Which Artery is Blocked? An Echo Challenge
https://www.medscape.com/viewarticle/844724

Jun 25th, 2015 - Slide 1. (Enlarge Slide) Ronald H. Wharton, MD: Good afternoon. This is Dr. Ronald Wharton from Montefiore Medical Center in the Bronx, New York. I thought I would share with you an interesting, and what I thought was an instructive, case. I call ...

Emergency Physicians Good at Spotting an Emerging MI
https://www.medpagetoday.com/emergencymedicine/emergencymedicine/10237

Jul 24th, 2008 - Action Points Explain to interested patients that the study supported the clinical impressions of emergency department physicians for MI. Note that the study was observational and may have been subject to bias as only patients who were worked up w...

Highlights of the XIX International Congress of Clinical Chemistry
https://www.medscape.com/viewarticle/516609

Nov 30th, 2005 - Introduction: Cardiac Markers: Something Old, Something New This update is based on a lecture given by Elliott Antman, MD,[1] cardiologist and clinical researcher at Harvard Medical School and Brigham and Women's Hospital in Boston, Massachusetts,...

Recall of Tosoh Bioscience Laboratory Analyzer Announced
https://www.medscape.com/viewarticle/495295

Dec 2nd, 2004 - Dec. 3, 2004 — The U.S. Food and Drug Administration (FDA) and Tosoh Bioscience, Inc., warned healthcare professionals via letter of a class 1 recall of AIA-600 II Enzyme Immunoassay analyzer software, version 3.02 and lower, for use with the ST A...

New diagnostic and prognostic cardiac markers in the setting of ACS
https://www.medscape.com/viewarticle/784033

Oct 2nd, 2001 - Wed, 03 Oct 2001 21:00:00 Boston, MA - New cardiac biomarkers used to diagnose or predict cardiovascular risk in acute coronary syndromes (ACS) may also be able to detect risk in patients who do not have increased levels of more traditionally test...

see more →